MONTREAL--(BUSINESS WIRE)--AmorChem, a leading venture fund dedicated to creating the next generation of biotech companies derived from academic research, introduced its rebranding this week. The fund is proud to present an entirely rethought visual image, through a new logo and website, as well as a move to new offices. The design of the new fund brand was propelled by a desire to reflect the unique role played by the fund in its ecosystem. Accordingly, the fresh logo, website and offices embody AmorChem’s vision: building an active and collaborative community of biotech start-ups from academic research and fostering a new generation of passionate science entrepreneurs.
Since its launch in 2011, the implementation of the fund’s vision has resulted in the successful financing of over 25 research programs in academia and the accelerated creation of several biotech companies, each with its own groundbreaking therapeutic paradigm.
“At AmorChem, we believe in the power of collaboration to help us transform innovative academic research into next generation biotech companies. A key goal of our rebranding was the creation of a physical space favourable to the flow of ideas, allowing us to welcome the passionate academics, interns, technology transfer officers, entrepreneurs, limited partners and venture investors who help us achieve our collective objectives,” explains Elizabeth Douville, founder and managing partner.
“We focus our core expertise in the translational steps that accelerate drug discovery and development across a broad spectrum of disease areas. Our new website highlights the diversity of innovative science in which we invest as well as the creative and dedicated people who have contributed and continue to help us to become the premier early stage venture fund in Canada,” says Ines Holzbaur, founder and managing partner.
“AmorChem essentially builds a bridge over the gap between promising academic research and successful biotech start-ups. The new shape of the AmorChem logo provides a visual reference to this bridge as well as a nod to the scientific world which lights the first spark,” adds Maxime Ranger, general partner.
The new website and the logo can now be seen at www.amorchem.com. The team has moved to 4 Westmount Square, Suite 160, Westmount (Québec), H3Z 2S6.
AmorChem is a leading early stage venture capital fund launched in 2011 in Montreal. The AmorChem team utilizes its deep understanding of fundamental science to uncover its therapeutic potential and focuses its core expertise in translational research to accelerate therapeutic drug discovery and development across a broad spectrum of disease areas. The fund capitalises on both its venture capital expertise and its entrepreneurial experience to spark the creation of start-up companies and help shape them into the next generation of biotech companies. With over $85M under management, AmorChem has financed over 25 university projects and started up several biotechnology companies from the fruits of this innovative research.